DiaSorin SpA Company Top Insiders

DSRLF Stock  USD 106.85  0.32  0.30%   
DiaSorin SpA employs about 3.3 K people. The company is managed by 9 executives with a total tenure of roughly 51 years, averaging almost 5.0 years of service per executive, having 368.11 employees per reported executive. Examination of DiaSorin SpA's management performance can provide insight into the company performance.
Carlo Rosa  CEO
CEO, General Manager and Executive Director
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaSorin SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

DiaSorin SpA Management Team Effectiveness

The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.

DiaSorin SpA Workforce Comparison

DiaSorin SpA is one of the top stocks in number of employees category among its peers. The total workforce of Diagnostics & Research industry is currently estimated at about 419,822. DiaSorin SpA maintains roughly 3,313 in number of employees contributing less than 1% to equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

DiaSorin SpA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. DiaSorin SpA Price Series Summation is a cross summation of DiaSorin SpA price series and its benchmark/peer.

DiaSorin SpA Notable Stakeholders

A DiaSorin SpA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DiaSorin SpA often face trade-offs trying to please all of them. DiaSorin SpA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DiaSorin SpA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carlo RosaCEO, General Manager and Executive DirectorProfile
Piergiorgio PedronSenior Corporate VP and CFOProfile
Chen EvenChief Commercial Officer and Executive DirectorProfile
Riccardo FavaDirector of Investor Relations and Corporate CommunicationProfile
Stefano RonchiSr. Corporate VP of HRProfile
Fabrizio BonelliChief OfficerProfile
Ulisse SpadaMang DepartmentProfile
Angelo RagoPres CorpProfile
Ugo GaySr OperationsProfile

About DiaSorin SpA Management Performance

The success or failure of an entity such as DiaSorin SpA often depends on how effective the management is. DiaSorin SpA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DiaSorin management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DiaSorin management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.

DiaSorin SpA Workforce Analysis

Traditionally, organizations such as DiaSorin SpA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DiaSorin SpA within its industry.

DiaSorin SpA Manpower Efficiency

Return on DiaSorin SpA Manpower

Revenue Per Employee373.6K
Revenue Per Executive137.5M
Net Income Per Employee93.9K
Net Income Per Executive34.6M
Working Capital Per Employee73.6K
Working Capital Per Executive27.1M

Complementary Tools for DiaSorin Pink Sheet analysis

When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine